School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

BIO-TECHNE Corp TECH

Healthcare · Biotechnology

$72.46last close 2026-10-09 · market cap $11.36B · delayed data

Trailing returns

1M+0.29%
3M+1.95%
6M+30.78%
1Y+21.65%
5Y-38.17%

Basis: Adjusted daily closes.

What it does

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology.

Open TECH in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies